Connect with Us at
ASCO!
Come see us at Booth #13155
Join our executive and medical team at ASCO and discover how Everest Clinical Research partners with oncology innovators to move complex studies forward—faster, smarter, and with confidence in data quality.
Your Niche Oncology CRO.
For more than 22 years, Everest Clinical Research has supported sponsors across the oncology landscape—from first-in-human studies to late-phase development.
In just the past 5 years, we’ve:
- Partnered with 1/3 of the oncology biotech market
- Supported 200+ cancer studies, across phases, indications, modalities, and difference countries
- Achieved a 95% client approval rating
Our teams combine scientific rigor, operational excellence, and a data-first approach to help oncology programs stay on track and decision-ready.
Meet the ASCO Team
Book Your Meeting Now
Complete the form below to schedule a consultation with our executive team attending ASCO. We will respond promptly to find a convenient time and location to meet on site.
News from Everest Clinical Research
Configurable vs Customizable Platforms and How to Choose the Right Approach for Your Study
Clinical trial protocols are becoming more complex than ever—driven by adaptive designs, biomarker-based decision-making, decentralized elements, and…
How Bayesian Dose-Finding Designs Can Accelerate Early-Phase Oncology Clinical Research
Historically used more frequently in exploratory analyses, Bayesian approaches are now increasingly recognized as viable frameworks for primary analysis in drug and biologic development—when appropriately designed and justified.
Everest Clinical Research Named Finalist of Fierce Outsourcing Awards for Excellence in Client Partnership
Everest Clinical Research has been named a 2026 finalist in the Excellence in Client Partnership category for the Fierce Outsourcing Awards.
Who Should Own Your Clinical Study URL? A Practical Guide for Sponsors
It sounds like a small administrative detail—but in practice, URL ownership shapes how your trial operates from day one through closeout. It can influence everything from study startup timelines to change control processes, migration costs, and long-term data governance.
Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) Announce Biostatistics Partnership to Advance Research in Friedreich’s Ataxia
TORONTO and PHILADELPHIA — February 27, 2026 —Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA)…
Everest Clinical Research to Expand Asia Pacific Operations with New Biometrics Team in the Philippines
Expansion will strengthen global biometrics delivery and support continued growth across the globe TORONTO — February 3,…
Everest Clinical Research Welcomes Amy Nguyen as Chief Commercial Officer to Drive Continued Global Growth
TORONTO, December 17, 2025 — Everest Clinical Research, a global, full-service CRO, announces the appointment of Amy…